Abstract | BACKGROUND: Ischemic preconditioning (IPC) decreases infarct size after global or regional ischemia. Potassium channel openers also precondition but are subject to dose-limiting vasodilation. We compared the mechanical and electrophysiological effects of ischemic and pharmacological preconditioning in an isolated rabbit heart model. METHODS: Rabbit hearts were preconditioned with either 10 micromol/L pinacidil alone (P-), 10 micromol/L pinacidil with 10 micromol/L phenylephrine (P+), or two cycles of global ischemia and reperfusion (IPC) before 1 hour of LAD occlusion. Left ventricular pressure, epicardial monophasic action potential duration (APD) and coronary flow were monitored throughout. Infarct size was determined at the end of reperfusion. RESULTS: Regional ischemia uniformly decreased APD (p<0.05). During reperfusion, APDs were prolonged beyond preischemic values in all preconditioned groups (p<0.05). P- and P+ reduced the incidence of fibrillation. P- significantly increased coronary flow (+15%, p = 0.001), whereas IPC and P+ did not. However, IPC and P- significantly decreased systolic function (p<0.05) but P+ did not. In addition, IPC depressed diastolic function (p<0.05) but P- and P+ did not. Infarct size was reduced by all methods (p<0.05). CONCLUSIONS:
Pinacidil presents a safe and effective alternative to IPC for preserving the heart during regional ischemia. Its coronary vasodilatory effects are safely and effectively reversed by the addition of phenylephrine.
|
Authors | A E Saltman, I B Krukenkamp, G R Gaudette, H Horimoto, S Levitsky |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 70
Issue 2
Pg. 595-601
(Aug 2000)
ISSN: 0003-4975 [Print] Netherlands |
PMID | 10969686
(Publication Type: Journal Article)
|
Chemical References |
- Vasodilator Agents
- Pinacidil
|
Topics |
- Action Potentials
(drug effects)
- Animals
- Coronary Circulation
- Heart
(drug effects)
- Ischemic Preconditioning, Myocardial
(methods)
- Male
- Pinacidil
(pharmacology)
- Rabbits
- Vasodilator Agents
(pharmacology)
|